Is CDKN2A p.Pro48Gln (c.143C>A) pathogenic?

CDKN2A p.Pro48Gln (c.143C>A) is classified Uncertain significance in CDKN2A (ClinVar, Multiple submitters, 3 submitters; last evaluated 2026-02-11). AlphaMissense: likely pathogenic (0.9466); Absent from gnomAD v4.1; Associated with hereditary neoplastic syndrome.

What condition is associated with CDKN2A p.Pro48Gln (c.143C>A)?

CDKN2A p.Pro48Gln (c.143C>A) is associated with hereditary neoplastic syndrome, melanoma-pancreatic cancer syndrome, familial melanoma (ClinVar).

How common is CDKN2A p.Pro48Gln (c.143C>A) in the general population?

CDKN2A p.Pro48Gln (c.143C>A) is absent from gnomAD v4.1 (gnomAD).

What do computational predictors say about CDKN2A p.Pro48Gln (c.143C>A)?

AlphaMissense predicts likely pathogenic (score 0.9466) — an in-silico prediction, not a clinical call.

CDKN2A p.Pro48Gln

c.143C>A · rs763804037 · VCV1042953

Uncertain significance Multiple submitters

Classification

Uncertain significance

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 3 submitters

AlphaMissense

likely pathogenic

0.9466 · ACMG-weighted

gnomAD v4.1

Absent

absent from gnomAD v4.1

Missense predictors

3/3 damaging

AlphaMissense, REVEL, SaProt

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
AlphaMissense	0.9466	likely pathogenic · top 6% in CDKN2A
REVEL	0.753	pathogenic-leaning
SaProt	LLR -17.62	damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 8.2	GERP 2, phastCons 1
Regional constraint	o/e 1.13	unconstrained · MANE · 6,595 bp · p 0.04 · regional, not allelic
Overall
CADD	25.6	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene: CDKN2A
Protein: p.Pro48Gln
Coding: c.143C>A
MANE Select: NM_000077
dbSNP: rs763804037
Type: single nucleotide variant
Location: chr9:21974685 (GRCh38)
Gene constraint: LOEUF 0.791 · pLI 0.62 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 77.02 · 5 PDB
Residue 48: an α-helix; a UniProt-annotated variant site (in cmm2; also found in head and neck tumor; somatic mutation); the 'interaction with cdk5rap3 and mdm2' region

Full CDKN2A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: melanoma-pancreatic cancer syndrome familial melanoma

Similar variants

CDKN2A p.Pro48Leu Pathogenic/Likely pathogenic ★★ same residue
CDKN2A p.Pro48Thr Pathogenic/Likely pathogenic ★★ same residue
CDKN2A p.Met48Leu Uncertain significance ★ same residue
CDKN2A p.Pro48Arg Conflicting classifications of pathogenicity ★ ⚠ same residue
CDKN2A p.Pro48= Likely benign ★ same residue
CDKN2A p.Pro48fs Pathogenic ★ same residue
CDKN2A c.150+1G>A Likely pathogenic ★★ same condition
CDKN2A c.150+2T>G Likely pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdkn2a-p-pro48gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown